Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 3503

INTRODUCTION: Serum proteomics and mutations in the epidermal growth factor receptor (EGFR) and KRAS have been associated with benefit after therapy with EGFR-targeted therapies in non-small cell lung cancer, but all three have not been evaluated in any one study. HYPOTHESIS: Pretreatment serum prot...

Full description

Saved in:
Bibliographic Details
Main Authors: Amann, Joseph M., Lee, Ju-Whei, Roder, Heinrich, Brahmer, Julie, Gonzalez, Adriana, Schiller, Joan H., Carbone, David P.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087978/
https://ncbi.nlm.nih.gov/pubmed/20035238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181c8cbd9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items